NCT00320632View on ClinicalTrials.gov

Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression

PHASE4CompletedINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

August 31, 1990

Study Completion Date

July 31, 1993

Conditions

Depression

Interventions

DRUG

Desipramine

Trial Locations (1)

02115

Massachusetts Mental Health Center, Boston

All Listed Sponsors

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Harvard Medical School (HMS and HSDM)

OTHER